Artículos por temáticas

Transcranial direct current stimulation and cognitive training in the rehabilitation of Alzheimer disease: A case study

Penolazzi B, Bergamaschi S, Pastore M, Villani D, Sartori G, Mondini S.

Neuropsychol Rehabil. 2015;25(6):799-817. doi: 10.1080/09602011.2014.977301. Epub 2014 Nov 7.

Role of traditional nonsteroidal anti-inflammatory drugs in Alzheimer's disease: a meta-analysis of randomized clinical trials

Gupta PP, Pandey RD, Jha D, Shrivastav V, Kumar S.

Am J Alzheimers Dis Other Demen. 2015 Mar;30(2):178-82. doi: 10.1177/1533317514542644. Epub 2014 Jul 13.

A Pilot Evaluation of Psychosocial Support for Family Caregivers of Relatives with Dementia in Long-Term Care: The Residential Care Transition Module

Gaugler JE, Reese M, Sauld J.

Res Gerontol Nurs. 2015 Jul-Aug;8(4):161-72. doi: 10.3928/19404921-20150304-01. Epub 2015 Mar 10.

Evaluating Response to High-Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease

Farlow MR, Sadowsky CH, Velting DM, Meng X, Islam MZ.

CNS Neurosci Ther. 2015 Jun;21(6):513-9. doi: 10.1111/cns.12385. Epub 2015 Feb 10.

A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers

Boinpally R, Chen L, Zukin SR, McClure N, Hofbauer RK, Periclou A.

Clin Drug Investig. 2015 Jul;35(7):427-35. doi: 10.1007/s40261-015-0296-4.

Observational and ecological studies of dietary advanced glycation end products in national diets and Alzheimer's disease incidence and prevalence

Perrone L, Grant WB.

J Alzheimers Dis. 2015;45(3):965-79. doi: 10.3233/JAD-140720.

Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial

Forstmeier S, Maercker A, Savaskan E, Roth T.

Trials. 2015 Nov 17;16:526. doi: 10.1186/s13063-015-1043-0.

Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease

Walker D, Lue LF, Paul G, Patel A, Sabbagh MN.

Expert Opin Investig Drugs. 2015 Mar;24(3):393-9. doi: 10.1517/13543784.2015.1001490. Epub 2015 Jan 14.

Fermenting soybeans with Bacillus licheniformis potentiates their capacity to improve cognitive function and glucose homeostaisis in diabetic rats with experimental Alzheimer's type dementia

Yang HJ, Kwon DY, Kim HJ, Kim MJ, Jung DY, Kang HJ, Kim DS, Kang S, Moon NR, Shin BK, Park S.

Eur J Nutr. 2015 Feb;54(1):77-88. doi: 10.1007/s00394-014-0687-y. Epub 2014 Apr 4.

Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore

Szałaj N, Bajda M, Dudek K, Brus B, Gobec S, Malawska B.

Arch Pharm (Weinheim). 2015 Aug;348(8):556-63. doi: 10.1002/ardp.201500117. Epub 2015 May 29.

Cognitive Results of CANTAB Tests and Their Change Due to the First Dose of Donepezil May Predict Treatment Efficacy in Alzheimer Disease

Kuzmickienė J, Kaubrys G.

Med Sci Monit. 2015 Dec 14;21:3887-99. doi: 10.12659/msm.896327.

Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia

Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S.

J Alzheimers Dis. 2015;44(3):897-906. doi: 10.3233/JAD-141791.

Predictive factors of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease and mixed dementia: a one-year naturalistic study

Miranda LF, Gomes KB, Silveira JN, Pianetti GA, Byrro RM, Peles PR, Pereira FH, Santos TR, Assini AG, Ribeiro VV, Tito PA, Matoso RO, Lima TO, Moraes EN, Caramelli P.

J Alzheimers Dis. 2015;45(2):609-20. doi: 10.3233/JAD-142148.

Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study

Gauthier S, Rountree S, Finn B, LaPlante B, Weber E, Oltersdorf T.

J Alzheimers Dis. 2015;48(2):473-81. doi: 10.3233/JAD-150414.

Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease

Wischik CM, Staff RT, Wischik DJ, Bentham P, Murray AD, Storey JM, Kook KA, Harrington CR.

J Alzheimers Dis. 2015;44(2):705-20. doi: 10.3233/JAD-142874.